| 摘要 |
<p>Disclosed is a hepatitis C virus (HCV) inhibitor which can affect the replication of HCV or the translation of a HCV protein. Specifically disclosed is an HCV inhibitor comprising a compound selected from compounds represented by the formulae (I) to (III) and (V) and pharmaceutically acceptable salts and solvates of the compounds [in the formulae, R<SUP>1</SUP> to R<SUP>3</SUP>, R<SUP>5</SUP> to R<SUP>6</SUP> and R<SUP>8</SUP> to R<SUP>9</SUP> independently represent a group selected from a hydrogen atom, a halogen atom, a linear or branched saturated or unsatuarted aliphatic hydrocarbon group, or a cycloalkyl, aryl, aralkyl, alkyloxy, alkenyloxy, alkynyloxy, aryloxy and aralkyloxy group which may have a substituent.</p> |
